top of page

AMRX

Amneal Pharmaceuticals Inc - Class A

$1.33

+0.02 (+1.53%)

chg neg

quotes and stock data may be delayed 15 minutes

 My Notes

Only BPIQ Pro members can create company notes. Learn more here.

52 wk low

1.28

52 wk hi

4.6

Cash

$212.1M

Burn Rate (Qtr)

NA

Mkt Cap

$201.5m

Avg Volume

1,186,356

*cash/burn updated:

Q1 '22

Drug Pipeline

Click the button to see the updated pipeline

No drug found

We don't have any drug data for this company yet

Drug | Disease (links)

Stage (next event)

Catalyst Date

Drug Name

Indication

Phase

Event

Exp Date

A free account is required to see the catalyst dates, notes, and more!

Loading Catalysts...

search in progress

Pipeline powered by

AMRX

BPIQ_Logo_RGB-01.jpg

Company Profile

Amneal Pharmaceuticals, Inc. (NYSE: AMRX) is an integrated specialty pharmaceutical company powered by a robust U.S. generics business and a growing branded business. Together, our team is working to build one of the most dynamic pharmaceutical companies in our rapidly changing industry.

Recent Posts

See what the community is saying - click to see full post.

bottom of page